eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Shire Human Genetic Therapies

Hampshire International Business Park, Crockford Lane, Basingstoke, Hampshire, RG24 8EP, UK
Telephone: +44 (0)1256 894000
Medical Information e-mail: hgtmedcomm@shire.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Summary of Product Characteristics last updated on the eMC: 18/11/2010
SPC VPRIV 400 Units powder for solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 18/11/2010 and displayed until Current
Reasons for adding or updating:
  • Change to section 6. 5 - Nature and Contents of Container
  • Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   03-Nov-2010
Legal Category:   POM
Black Triangle (CHM):   YES

Free-text change information supplied by the pharmaceutical company



In section 6.5 Nature and contents of container - text for 5 and 25 vials has been added as follows:

 

Pack sizes of 1, 5 and 25 vials.

Not all pack sizes may be marketed.

In section 8 Marketing Authorisation Number(s), the following have been added:
EU/1/10/646/005
EU/1/10/646/006

In section 10 Date of Revision of the text - 03/11/2010 has been added.

Updated on 04/11/2010 and displayed until 18/11/2010
Reasons for adding or updating:
  • New SPC for new product
Date of revision of text on the SPC:  
Legal Category:   POM
Black Triangle (CHM):   YES

Free-text change information supplied by the pharmaceutical company

None provided

Active Ingredients/Generics

 
   velaglucerase alfa